Bocci, Matteo http://orcid.org/0000-0002-8774-0006
Sjölund, Jonas http://orcid.org/0000-0002-6992-3415
Kurzejamska, Ewa http://orcid.org/0000-0002-8050-6516
Lindgren, David
Marzouka, Nour-Al-Dain http://orcid.org/0000-0002-9029-3702
Bartoschek, Michael http://orcid.org/0000-0002-1567-795X
Höglund, Mattias http://orcid.org/0000-0001-9283-4421
Pietras, Kristian http://orcid.org/0000-0001-6738-4705
Funding for this research was provided by:
European Research Council (309322 TUMORGAN)
Cancerfonden
Vetenskapsrådet
Fru Berta Kamprads Stiftelse
Article History
Received: 1 April 2018
Accepted: 13 August 2018
First Online: 21 August 2018
Compliance with ethical standards
:
: KP is listed as an inventor on a patent describing the use of ALK1 inhibitors in cancer.